INTRODUCTION: Recent advances in microsurgery such as lymphaticovenous bypass (LVB) have been shown to decrease limb volumes and improve subjective symptoms in patients with lymphedema. However, to date, it remains unknown if these procedures can reverse the pathological tissue changes associated with lymphedema. Therefore, the purpose of this study was to analyze skin tissue changes in patients before and after LVB. METHODS AND RESULTS: Matched skin biopsy samples were collected from normal and lymphedematous limbs of 6 patients with unilateral breast cancer-related upper extremity lymphedema before and 6 months after LVB. Biopsy specimens were fixed and analyzed for inflammation, fibrosis, hyperkeratosis, and lymphangiogenesis. Six months following LVB, 83% of patients had symptomatic improvement in their lymphedema. Histological analysis at this time demonstrated a significant decrease in tissue CD4(+) cell inflammation in lymphedematous limb (but not normal limb) biopsies (p<0.01). These changes were associated with significantly decreased tissue fibrosis as demonstrated by decreased collagen type I deposition and TGF-β1 expression (all p<0.01). In addition, we found a significant decrease in epidermal thickness, decreased numbers of proliferating basal keratinocytes, and decreased number of LYVE-1(+) lymphatic vessels in lymphedematous limbs after LVB. CONCLUSIONS: We have shown, for the first time, that microsurgical LVB not only improves symptomatology of lymphedema but also helps to improve pathologic changes in the skin. These findings suggest that the some of the pathologic changes of lymphedema are reversible and may be related to lymphatic fluid stasis.
INTRODUCTION: Recent advances in microsurgery such as lymphaticovenous bypass (LVB) have been shown to decrease limb volumes and improve subjective symptoms in patients with lymphedema. However, to date, it remains unknown if these procedures can reverse the pathological tissue changes associated with lymphedema. Therefore, the purpose of this study was to analyze skin tissue changes in patients before and after LVB. METHODS AND RESULTS: Matched skin biopsy samples were collected from normal and lymphedematous limbs of 6 patients with unilateral breast cancer-related upper extremity lymphedema before and 6 months after LVB. Biopsy specimens were fixed and analyzed for inflammation, fibrosis, hyperkeratosis, and lymphangiogenesis. Six months following LVB, 83% of patients had symptomatic improvement in their lymphedema. Histological analysis at this time demonstrated a significant decrease in tissue CD4(+) cell inflammation in lymphedematous limb (but not normal limb) biopsies (p<0.01). These changes were associated with significantly decreased tissue fibrosis as demonstrated by decreased collagen type I deposition and TGF-β1 expression (all p<0.01). In addition, we found a significant decrease in epidermal thickness, decreased numbers of proliferating basal keratinocytes, and decreased number of LYVE-1(+) lymphatic vessels in lymphedematous limbs after LVB. CONCLUSIONS: We have shown, for the first time, that microsurgical LVB not only improves symptomatology of lymphedema but also helps to improve pathologic changes in the skin. These findings suggest that the some of the pathologic changes of lymphedema are reversible and may be related to lymphatic fluid stasis.
Authors: Antonio J Forte; Andrea Sisti; Maria T Huayllani; Daniel Boczar; Gabriela Cinotto; Pedro Ciudad; Oscar J Manrique; Xiaona Lu; Sarah McLaughlin Journal: Gland Surg Date: 2020-04
Authors: Betty J Smoot; Judy Mastick; John Shepherd; Steven M Paul; Kord M Kober; Bruce A Cooper; Yvette P Conley; Niharika Dixit; Marilyn J Hammer; Mei R Fu; Gary Abrams; Christine Miaskowski Journal: Lymphat Res Biol Date: 2021-11-18 Impact factor: 2.349
Authors: Jason C Gardenier; Raghu P Kataru; Geoffrey E Hespe; Ira L Savetsky; Jeremy S Torrisi; Gabriela D García Nores; Dawit K Jowhar; Matthew D Nitti; Ryan C Schofield; Dean C Carlow; Babak J Mehrara Journal: Nat Commun Date: 2017-02-10 Impact factor: 14.919
Authors: Anouk J M Cornelissen; Melissa Kool; Tiara R Lopez Penha; Xavier H A Keuter; Andrzej A Piatkowski; E Heuts; René R W J van der Hulst; Shan Shan Qiu Journal: Breast Cancer Res Treat Date: 2017-03-07 Impact factor: 4.872
Authors: Jung-Ju Huang; Jason C Gardenier; Geoffrey E Hespe; Gabriela D García Nores; Raghu P Kataru; Catherine L Ly; Inés Martínez-Corral; Sagrario Ortega; Babak J Mehrara Journal: PLoS One Date: 2016-12-12 Impact factor: 3.240
Authors: Joost Wolfs; Jop Beugels; Merel Kimman; Andrzej A Piatkowski de Grzymala; Esther Heuts; Xavier Keuter; Hanneke Tielemans; Dietmar Ulrich; R van der Hulst; Shan Shan Qiu Journal: BMJ Open Date: 2020-01-15 Impact factor: 2.692